CAPITOL HILL CONSULTING GROUP for ENDO PHARMACEUTICALS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 13, 2011 | $30,000 | Replaced |
| 3rd Quarter - Amendment | Oct 18, 2011 | $30,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
| DAVID JORY | — |
Medicare/Medicaid MMM
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
| DAVID JORY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.